STOCK FOCUS OF THE DAY
Bursa Malaysia : 2QFY15: Results in line, buoyed by
derivatives
Hold
We maintain our HOLD recommendation on Bursa Malaysia with
an unchanged fair value of RM8.90/share, based on FY15F PE of 23x. Bursa
reported 2QFY15 net profit of RM49.5mil (QoQ: +5.2%) to extend its 1HFY15 earnings
to RM96.5mil. The results were within expectations, accounting for 47% of our
and 48% of market estimates.
Management declared an interim dividend of 16.5sen, which is
equivalent to a payout ratio of 91%. No special dividend is expected in the near
term. Despite the pared down market sentiment due to the difficult domestic and
global environment, Bursa’s performance in 1HFY15 is commendable, slightly
buoyed by growth in its derivatives and Islamic products.
Derivatives trading revenue in 1HFY15 grew by 11.9% YoY,
mainly attributed to the volatile palm oil prices during the quarter, which
spurred FCPO trades (FCPO makes up 81% of the ADC). Its BSAS trading revenue
(Islamic product) also doubled. Equities trading revenue, which is Bursa’s key
contributor, was unchanged at RM116mil.
However, Bursa’s securities market statistics disappointed
slightly, with Average Daily Traded Value (ADTV) lower at RM2bil (YoY: -8%).
Also trading velocity dropped 2ppts to 28%. We believe that this is due to the
poor retail participation and market sentiment. On the other hand, foreign
shareholding declined by only by 1ppt to 28%, with foreign ADTV of RM550mil
during these challenging times.
Looking ahead, the market environment for the remaining of
FY15 will be challenging. However, we believe the growth of its derivatives and
Islamic products, as well as further IPO revenue will negate any negativity
felt from the equities market. Bursa had earlier this week loosened its
regulations for the ACE market to attract more listings. We leave our
FY15F-FY17F earnings estimates unchanged. The stock is currently trading at 21x
FY15F PE, slightly below its 5-year PE average of 22x.
Others :
Tenaga Nasional : Proposes to buy 1MDB’s power
portfolio Buy
Economic Update : Inflation continues to escalate amid
higher petrol pump prices
QUICK TAKE
Parkson Holdings : Undergoing internal group
reorganisation Buy
NEWS HIGHLIGHTS
IHH Healthcare : Turkey to develop technology-based products
DISCLAIMER:
The information and opinions in this report were prepared by
AmResearch Sdn Bhd. The investments discussed or recommended in this report may
not be suitable for all investors. This report has been prepared for
information purposes only and is not an offer to sell or a solicitation to buy
any securities. The directors and employees of AmResearch Sdn Bhd may from time
to time have a position in or with the securities mentioned herein. Members of
the AmInvestment Group and their affiliates may provide services to any company
and affiliates of such companies whose securities are mentioned herein. The
information herein was obtained or derived from sources that we believe are
reliable, but while all reasonable care has been taken to ensure that stated
facts are accurate and opinions fair and reasonable, we do not represent that
it is accurate or complete and it should not be relied upon as such. No
liability can be accepted for any loss that may arise from the use of this
report. All opinions and estimates included in this report constitute our
judgement as of this date and are subject to change without notice.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.